Evidence map›Paper›PMID 10973443›Full record

ReviewClinical and diagnostic laboratory immunology2000

Detection and function of opioid receptors on cells from the immune system.

J M Bidlack

Abstract readReview
In one paragraph

Review in Clinical and diagnostic laboratory immunology, 2000. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 68 papers.

0numbers the graph read from it
0cells of the map it votes in
68citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

68 citing papers in PubMed.

  1. Article
  2. Opioid Signaling in Multiple Sclerosis: Emerging Targets for Repair.International journal of molecular sciences · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. PKA inhibition is a central step in D,L-methadone-induced ER CaFrontiers in cell and developmental biology · 2024
    Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

8 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

J M BidlackDepartment of Pharmacology and Physiology, School of Medicine and Dentistry, University of Rochester, Rochester, New York 14642, USA. Jean_Bidlack@urmc.rochester.edu

Funding

OPIOID RECEPTORS ON LYMPHOCYTES AND BRAINK05DA000360 · NIDA · UNIVERSITY OF ROCHESTER · PI BIDLACK, JEAN M · 1998 to 2007
$893k
OPIOID MODULATION OF IMMUNOCOMPETENCER01DA004355 · NIDA · UNIVERSITY OF ROCHESTER · PI BIDLACK, JEAN M · 1989 to 2003
$837k
NIDA NIH HHS DA04355NIDA NIH HHS K05 DA000360NIDA NIH HHS K05-DA00360NIDA NIH HHS R01 DA004355
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsHumansImmune SystemLymphocytesReceptors, OpioidReceptors, Opioid, deltaReceptors, Opioid, kappaReceptors, Opioid, muReceptors, OpioidReceptors, Opioid, deltaReceptors, Opioid, kappaReceptors, Opioid, mu

Identifiers

PMID10973443
PMCPMC95944

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.